Epidemiology and Costs of Sepsis in the United States—An Analysis Based on Timing of Diagnosis and Severity Level*

Objectives: To characterize the current burden, outcomes, and costs of managing sepsis patients in U.S. hospitals. Design: A retrospective observational study was conducted using the Premier Healthcare Database, which represents ~20% of U.S. inpatient discharges among private and academic hospitals. Hospital costs were obtained from billing records per the cost accounting method used by each hospital. Descriptive statistics were performed on patient demographics, characteristics, and clinical and economic outcomes for the index hospitalization and 30-day readmissions. Setting: Sepsis patient hospitalizations, including inpatient, general ward, and ICU (intermediate and/or step-down). Patients: Adults over 18 years old with a hospital discharge diagnosis code of sepsis from January 1, 2010, to September 30, 2016. Interventions: None. This was a retrospective observational study of deidentified data. Measurements and Main Results: The final study cohort consisted of 2,566,689 sepsis cases, representing patients with a mean age of 65 years (50.8% female). Overall mortality was 12.5% but varied greatly by severity (5.6%, 14.9%, and 34.2%) for sepsis without organ dysfunction, severe sepsis, and septic shock, respectively. Costs followed a similar pattern increasing by severity level: $16,324, $24,638, and $38,298 and varied widely by sepsis present at admission ($18,023) and not present at admission ($51,022). Conclusions: The highest burden of incidence and total costs occurred in the lowest severity sepsis cohort population. Sepsis cases not diagnosed until after admission, and those with increasing severity had a higher economic burden and mortality on a case-by-case basis. Methods to improve early identification of sepsis may provide opportunities for reducing the severity and economic burden of sepsis in the United States.

[1]  György J. Simon,et al.  Delay Within the 3-Hour Surviving Sepsis Campaign Guideline on Mortality for Patients With Severe Sepsis and Septic Shock* , 2018, Critical care medicine.

[2]  Susan Gruber,et al.  Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014 , 2017, JAMA.

[3]  G. Martin.  Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes , 2012, Expert review of anti-infective therapy.

[4]  Theodore J Iwashyna,et al.  Increased 1-year healthcare use in survivors of severe sepsis. , 2014, American journal of respiratory and critical care medicine.

[5]  C. Torio,et al.  National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011 , 2013 .

[6]  C. Camargo,et al.  Sepsis Visits and Antibiotic Utilization in U.S. Emergency Departments* , 2014, Critical care medicine.

[7]  M. J. Hall,et al.  Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. , 2011, NCHS data brief.

[8]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[9]  D. Warren,et al.  Quantifying the improvement in sepsis diagnosis, documentation, and coding: the marginal causal effect of year of hospitalization on sepsis diagnosis. , 2016, Annals of epidemiology.

[10]  J. Bartlett,et al.  Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. , 2004, Archives of internal medicine.

[11]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[12]  O. Moerer,et al.  [The cost of sepsis]. , 2006, Der Anaesthesist.

[13]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[14]  Stephen L. Jones,et al.  Outcomes and Resource Use of Sepsis-associated Stays by Presence on Admission, Severity, and Hospital Type , 2016, Medical care.

[15]  M. Levy,et al.  Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program* , 2014, Critical care medicine.

[16]  G. Escobar,et al.  Hospital deaths in patients with sepsis from 2 independent cohorts. , 2014, JAMA.

[17]  Steven Q Simpson,et al.  Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients , 2017, Critical care medicine.

[18]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[19]  C. Ginocchio,et al.  Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia. , 2003, American Journal of Respiratory and Critical Care Medicine.

[20]  G. Escobar,et al.  The Timing of Early Antibiotics and Hospital Mortality in Sepsis , 2017, American journal of respiratory and critical care medicine.

[21]  W. Judd,et al.  Clinical and Economic Impact of a Quality Improvement Initiative to Enhance Early Recognition and Treatment of Sepsis , 2014, The Annals of pharmacotherapy.